This page calculates the value of GlaxoSmithKline tokenized stock (rGSK) in Swiss Franc (CHF). Exchange rates are based on real-time trading data from the rGSK/USDT trading pair on the Bitget spot stock market.

rGSK is a Bitget rToken issued by Reality and backed 1:1 by GlaxoSmithKline shares. This means you can buy rGSK using crypto (such as USDT) without needing to open a U.S. stock account. Trading rGSK on Bitget offers the same experience as trading crypto such as BTC.

rGSK is a blockchain-based synthetic asset and an on-chain representation of the underlying stock. Holding this token does not constitute actual equity ownership in the underlying company and does not grant shareholder voting rights. However, holders are entitled to equivalent dividend distributions if the underlying stock pays dividends. Bitget converts the stock's dividend payouts into an equivalent amount of USDT and distributes it to token holders' Bitget accounts at a 1:1 ratio.

Risk warning: Trading financial derivatives such as tokenized stocks carries significant risk. Assess your risk tolerance and make informed decisions before investing.

1 GlaxoSmithKline (rGSK) equals40.91 Swiss Franc

Last updated as of 2026/09/03 16:49:07 (UTC+0)Refresh

From

rGSK

CHF

Bitget converter provides rGSK to CHF real-time exchange rates, making it easy to convert GlaxoSmithKline (rGSK) to Swiss Franc (CHF). The conversion result is based on real-time data. The conversion result shows that 1 rGSK is currently valued at 40.91 CHF. Since crypto prices can change rapidly, we recommend checking back for the conversion result.

rGSK to CHF chart

1D7D1M3M1YAll

rGSK/CHF: 1 rGSK = 40.91 CHF. The price of converting 1 GlaxoSmithKline (rGSK) to Swiss Franc (CHF) is 40.91 CHF today.

In the past 1D, GlaxoSmithKline has changed +0.06% to CHF. Based on the trend and price charts, GlaxoSmithKline(rGSK) has changed +0.06% to CHF while Swiss Franc(CHF) has changed % to rGSK in the last 24 hours.

Live rGSK price

What is Bitget rToken?

Bitget rToken is a new batch of tokenized stocks launched by Bitget on its spot trading market. These are tokenized assets pegged 1:1 to real U.S. stocks, offering an improved option for users who need real-time trading and flexible allocation between U.S. stocks and crypto assets.

All Bitget rTokens are issued by Reality, Bitget's licensed RWA protocol, which partners with compliant broker Alpaca to connect directly to global liquidity pools such as Nasdaq and the NYSE. Each rToken is backed by real stock held in 1:1 custody at a licensed broker, supporting native U.S. stock liquidity.

Key features of Bitget rToken (rGSK)

Asset attributeA tokenized stock pegged 1:1 to a real U.S. stock.

IssuerReality (Bitget's licensed RWA protocol).

DividendsDividends are automatically distributed to your account in USDT, with no manual action required.

Fractional shareSupports fractional share trading, starting from as low as 1 USDT.

Trading hoursSome rTokens offer native U.S. stock liquidity 24/5, while others support 24/7 trading.

How to buyCan be purchased directly with USDT, USDC, or BTC, with no conversion required.

Position usageCan be held as an investment position, and also used as combined margin for Bitget's unified trading account and USDT-M futures.

Asset security100% Proof of Reserves (verifiable at any time).Over $300 million user protection fund.

In short, rGSK is a tokenized stock issued by licensed issuer Reality, pegged 1:1 to real GlaxoSmithKline stock. It supports 24/7 trading, fractional shares, and dividends, and can be used as margin for the platform's unified trading account and USDT-M futures.

How Bitget rToken (rGSK) works

During U.S. market hours—including the regular session, pre-market, after-hours, and overnight sessions—spot orders for rGSK are routed directly through a broker to the Nasdaq or NYSE order book. Once the trade is executed on the U.S. stock market, the execution result is reflected in the on-exchange spot order record. Any order you place for rGSK while the U.S. market is open will also appear on the Nasdaq or NYSE order book. This means that during U.S. market hours, the trading price and liquidity of rGSK are exactly the same as those of the underlying stock. Orders for rGSK and their execution results are part of the U.S. stock market. There is no spread or so-called de-pegging, because rGSK trades are executed directly on the U.S. stock market itself. The execution price you see for rGSK is identical to the stock's price at that exact moment.

This makes rGSK fundamentally different from traditional RWA tokens. The price of a traditional RWA asset is determined by on-chain liquidity and trading activity, whereas the price of rGSK is directly equivalent to the stock price—it does not rely on any other mechanism to peg the asset's price. In terms of trading outcomes, trading rGSK is no different from trading the stock directly.

Buy/sell rGSK now

Convert between rGSK and fiat currencies on Bitget

The Bitget price calculator provides real-time conversion rates from rGSK to CHF and other currencies. Note that the calculator is only intended to calculate conversion values between rTokens and fiat currencies. Bitget does not support direct conversion between rTokens and fiat currencies, but you can convert between them indirectly on Bitget using USDT as an intermediary.

If you want to buy rGSK with fiat currency, follow these steps:

1. Sign up for a free Bitget account and complete identity verification.

2. Buy USDT with fiat currency on the Bitget fiat market.

3. Find the rGSK/USDT trading pair on the Bitget spot stock market to buy rGSK with USDT.

If you want to convert rGSK to fiat currency, follow these steps:

1. Log in to your Bitget account.

2. Find the rGSK/USDT trading pair on the Bitget spot stock market to convert rGSK to USDT.

3. After selling USDT on the Bitget fiat market, the fiat currency will be credited to your fiat account.

1 rGSK is currently valued at 40.91 CHF, which means buying 5 rGSK would cost 204.55 CHF. Similarly, Fr1 CHF can be converted to 0.02444 rGSK, and Fr50 CHF can be converted to 0.1222 rGSK, excluding any platform or gas fees.

Buy USDT now Trade rGSK/USDT

Buy USDT on the fiat market

Sell USDT on the fiat market

Merchants (trades/completion rate)	Price	Amount/limit Low to high	Payment methods	Zero fees Action

No matching ads found.

More offers Trade rGSK/USDT

Buy rGSK with USDT on the spot stock market, or convert rGSK to USDT.

Pair

Type

Price

24h volume

Action

rGSK/USDT

Spot

50.72

$5.39M

Trade

View the GlaxoSmithKline futures trading guide for more insights on GlaxoSmithKline futures and related data.

Convert rGSK to CHF

Convert CHF to rGSK

GlaxoSmithKline

Swiss Franc

1 rGSK

40.91 CHF

Exchange 1 rGSK for 40.91 CHF

2 rGSK

81.82 CHF

Exchange 2 rGSK for 81.82 CHF

5 rGSK

204.55 CHF

Exchange 5 rGSK for 204.55 CHF

10 rGSK

409.1 CHF

Exchange 10 rGSK for 409.1 CHF

20 rGSK

818.2 CHF

Exchange 20 rGSK for 818.2 CHF

50 rGSK

2,045.5 CHF

Exchange 50 rGSK for 2,045.5 CHF

100 rGSK

4,091 CHF

Exchange 100 rGSK for 4,091 CHF

200 rGSK

8,182 CHF

Exchange 200 rGSK for 8,182 CHF

500 rGSK

20,455 CHF

Exchange 500 rGSK for 20,455 CHF

1000 rGSK

40,910 CHF

Exchange 1000 rGSK for 40,910 CHF

5000 rGSK

204,550.02 CHF

Exchange 5000 rGSK for 204,550.02 CHF

10000 rGSK

409,100.05 CHF

Exchange 10000 rGSK for 409,100.05 CHF

In the table above, you'll find a comprehensive rGSK to CHF converter that shows the value of GlaxoSmithKline in Swiss Franc across commonly used conversion amounts. The list covers conversions from 1 rGSK to CHF, all the way up to 10000 rGSK, providing a clear view of their respective values.

Swiss Franc

GlaxoSmithKline

1 CHF

0.02444 rGSK

Exchange 1 CHF for 0.02444 rGSK

10 CHF

0.2444 rGSK

Exchange 10 CHF for 0.2444 rGSK

50 CHF

1.22 rGSK

Exchange 50 CHF for 1.22 rGSK

100 CHF

2.44 rGSK

Exchange 100 CHF for 2.44 rGSK

200 CHF

4.89 rGSK

Exchange 200 CHF for 4.89 rGSK

500 CHF

12.22 rGSK

Exchange 500 CHF for 12.22 rGSK

1000 CHF

24.44 rGSK

Exchange 1000 CHF for 24.44 rGSK

2000 CHF

48.89 rGSK

Exchange 2000 CHF for 48.89 rGSK

5000 CHF

122.22 rGSK

Exchange 5000 CHF for 122.22 rGSK

10000 CHF

244.44 rGSK

Exchange 10000 CHF for 244.44 rGSK

50000 CHF

1,222.19 rGSK

Exchange 50000 CHF for 1,222.19 rGSK

100000 CHF

2,444.39 rGSK

Exchange 100000 CHF for 2,444.39 rGSK

In the table above, you'll find a comprehensive CHF to rGSK converter that shows the value of Swiss Franc in GlaxoSmithKline across commonly used conversion amounts. The list covers conversions from 1 CHF to rGSK, all the way up to 100000 CHF, providing a clear view of their respective values.

rGSK to CHF Conversion tables

The exchange rate of GlaxoSmithKline is increasing.

The exchange rate of 1 rGSK to Swiss Franc has changed by +0.06% in the last 7 days. In the last 24 hours, the rate has fluctuated by +0.06%, reaching a high of 40.93 CHF and a low of 40.87 CHF . One month ago, the value of 1 rGSK was Fr40.75 CHF , which represents a +0.40% change from its current value. Over the last year, GlaxoSmithKline has changed by

+Fr

0.7956CHF

, resulting in a change of +18.72% in its value.

24 hours ago1 month ago1 year ago

Amount	16:49 today	24 hours ago	24h change
0.5 rGSK	Fr20.46	Fr20.44	+0.06%
1 rGSK	Fr40.91	Fr40.88	+0.06%
5 rGSK	Fr204.55	Fr204.42	+0.06%
10 rGSK	Fr409.1	Fr408.85	+0.06%
50 rGSK	Fr2,045.5	Fr2,044.25	+0.06%
100 rGSK	Fr4,091	Fr4,088.5	+0.06%
500 rGSK	Fr20,455	Fr20,442.48	+0.06%
1000 rGSK	Fr40,910	Fr40,884.97	+0.06%

rGSK to CHF FAQ

How much is 1 GlaxoSmithKline in CHF?

Right now, the price of 1 GlaxoSmithKline (rGSK) in Swiss Franc (CHF) is Fr40.91.

How much rGSK can I buy for 1 CHF?

Based on the current exchange rate, you can get 0.02444 rGSK for 1 CHF.

How do I calculate or convert rGSK to CHF?

You can use our rGSK to CHF calculator at the top of this page to convert any amount of rGSK to CHF. We've also included quick-reference tables for the most popular conversions. For example, 5 CHF is equivalent to 0.1222 rGSK, while 5 rGSK will cost around 204.55CHF.

What is the highest price of rGSK/CHF in history?

The all-time high price of 1 rGSK in CHF is Fr57.55. It remains to be seen if the value of 1 rGSK/CHF will exceed the current all-time high.

What is the price trend of GlaxoSmithKline in CHF?

Over the past 7 days, the exchange rate of GlaxoSmithKline (rGSK) has gone up by 0.06%. Over the last month, the exchange rate of GlaxoSmithKline (rGSK) has gone up by 0.40% against Swiss Franc (CHF).

What factors influence the conversion rate of rGSK to CHF?

There are many factors that affect the relationship between GlaxoSmithKline and Swiss Franc, spanning multiple dimensions such as macroeconomic trends, policy regulation, and technological innovation. Specifically, the following key factors play an important role:

Market sentiment:Investor sentiment and confidence have a significant impact on the dynamics of rGSK/CHF. When there is positive news in the market about the widespread adoption of rGSK or major technological breakthroughs, it tends to trigger market optimism and drive the rise of rGSK/CHF. Conversely, negative news, such as regulatory crackdowns and security vulnerabilities, may trigger market panic and lead to a decline in rGSK/CHF.

Regulatory environment:Government policies and regulations surrounding cryptocurrencies have a direct impact on their acceptance, which in turn determines their value relative to traditional currencies such as the US dollar. Clear and supportive regulations can enhance investor confidence in cryptocurrencies and drive their value up. Conversely, vague or overly strict regulatory policies may hinder the development of cryptocurrencies and cause their value to fall.

Economic indicators:Macroeconomic factors in the country where the fiat currency is issued—such as inflation rates, interest rates, and key economic growth indicators—play a crucial role in determining the fiat currency's value and indirectly affect the exchange rate of rGSK/CHF. For example, high inflation rates may lead to a decrease in market trust in fiat currencies, thereby increasing investors' demand for cryptocurrencies such as Bitcoin as a hedge, driving up their prices.

Technological progress:The continuous development and innovation of blockchain technology, as well as various improvements in the cryptocurrency ecosystem—such as expansion solutions and security enhancements—have provided strong support for the value growth of cryptocurrencies like Bitcoin.

Investors must understand these dynamics to avoid making wrong decisions. After considering these factors, investors should also closely monitor future changes in the price of GlaxoSmithKline and adjust their investment strategies accordingly in the evolving market.

Hot promotions

Popular rGSK conversions

1 rGSK to 50.65 USD

1 rGSK to 43.59 EUR

1 rGSK to 340.31 CNY

1 rGSK to 69.83 CAD

1 rGSK to 7874.50 JPY

rGSK to BRL

1 rGSK to 258.75 BRL

Popular CHF conversions

rAAPL to CHF

1 rAAPL to 266.38 CHF

rNVDA to CHF

1 rNVDA to 184.00 CHF

rQQQ to CHF

1 rQQQ to 579.57 CHF

rSPCX to CHF

1 rSPCX to 120.76 CHF

rSPY to CHF

1 rSPY to 624.50 CHF

rTSLA to CHF

1 rTSLA to 308.33 CHF

Popular rToken conversions

rMU to AUD

1 rMU to 1328.03 AUD

rSNDK to GBP

1 rSNDK to 1140.84 GBP

rMRVL to KRW

1 rMRVL to 280163.12 KRW

rPLTR to IDR

1 rPLTR to 2990294.79 IDR

rMSFT to TWD

1 rMSFT to 15785.04 TWD

rINTC to INR

1 rINTC to 8534.95 INR

Popular fiat

Popular areas

This content is being provided to you for informational purposes only, does not constitute an offer, or solicitation of an offer nor a recommendation by Bitget to buy, sell, or hold any security, financial product, or instrument referenced in the content, and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Data presented may reflect asset prices traded on the Bitget exchange as well as other cryptocurrency exchanges and market data platforms. Bitget may charge fees for the processing of cryptocurrency transactions which may not be reflected in the conversion prices displayed. Bitget is not liable for any errors or delays in content or for any actions taken in reliance on any content.